- Home
- NIPG vs HLVX Comparison
NIPG vs HLVX Comparison
Compare NIPG & HLVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NIPG
- HLVX
- Stock Information
- Founded
- NIPG 2014
- HLVX 2020
- Country
- NIPG Sweden
- HLVX United States
- Employees
- NIPG N/A
- HLVX N/A
- Industry
- NIPG
- HLVX Biotechnology: Pharmaceutical Preparations
- Sector
- NIPG
- HLVX Health Care
- Exchange
- NIPG NYSE
- HLVX Nasdaq
- Market Cap
- NIPG 73.7M
- HLVX 83.7M
- IPO Year
- NIPG 2024
- HLVX 2022
- Fundamental
- Price
- NIPG $1.54
- HLVX $1.96
- Analyst Decision
- NIPG Strong Buy
- HLVX Hold
- Analyst Count
- NIPG 1
- HLVX 5
- Target Price
- NIPG $6.00
- HLVX $2.33
- AVG Volume (30 Days)
- NIPG 129.3K
- HLVX 199.7K
- Earning Date
- NIPG 04-30-2025
- HLVX 05-08-2025
- Dividend Yield
- NIPG N/A
- HLVX N/A
- EPS Growth
- NIPG N/A
- HLVX N/A
- EPS
- NIPG N/A
- HLVX N/A
- Revenue
- NIPG $85,266,306.00
- HLVX N/A
- Revenue This Year
- NIPG $11.25
- HLVX N/A
- Revenue Next Year
- NIPG $33.33
- HLVX N/A
- P/E Ratio
- NIPG N/A
- HLVX N/A
- Revenue Growth
- NIPG 1.91
- HLVX N/A
- 52 Week Low
- NIPG $0.99
- HLVX $1.34
- 52 Week High
- NIPG $17.76
- HLVX $15.60
- Technical
- Relative Strength Index (RSI)
- NIPG N/A
- HLVX 59.85
- Support Level
- NIPG N/A
- HLVX $1.82
- Resistance Level
- NIPG N/A
- HLVX $1.89
- Average True Range (ATR)
- NIPG 0.00
- HLVX 0.07
- MACD
- NIPG 0.00
- HLVX -0.01
- Stochastic Oscillator
- NIPG 0.00
- HLVX 63.64
About NIPG NIP GROUP INC SPON ADS EACH REPR 2 CL A ORD SHS
NIP Group Inc is a digital entertainment company built for the growing gaming and esports industry. NIP Group integrates multiple businesses such as talent agency, event production, game-themed hotels and game publishing to create transformative entertainment experiences that inspire, connect fans, expand global influence, and achieve deep interaction on platforms where digital native players gather. It currently has operation centers in Sweden, China, Abu Dhabi, and Brazil, and its esports teams cover multiple game projects and are active in the top event stages.
About HLVX HilleVax Inc.
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.